These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 8399589)
21. Recovery of gastrointestinal function after renal transplantation in patients with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis. Bhandari S Am J Kidney Dis; 1996 Apr; 27(4):604. PubMed ID: 8678075 [No Abstract] [Full Text] [Related]
22. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis. Zemel D; Struijk DG; Dinkla C; Stolk LM; ten Berge IJ; Krediet RT J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393 [TBL] [Abstract][Full Text] [Related]
23. The time course of peritoneal transport kinetics in continuous ambulatory peritoneal dialysis patients who develop sclerosing peritonitis. Krediet RT; Struijk DG; Boeschoten EW; Koomen GC; Stouthard JM; Hoek FJ; Arisz L Am J Kidney Dis; 1989 Apr; 13(4):299-307. PubMed ID: 2705448 [TBL] [Abstract][Full Text] [Related]
24. [The effect of the number of peritonitis episodes on peritoneal membrane function]. Jovanović D; Nesić V; Dimitrijević Z Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837 [TBL] [Abstract][Full Text] [Related]
25. Peritonitis: pathophysiology and local defense mechanisms. Heemken R; Gandawidjaja L; Hau T Hepatogastroenterology; 1997; 44(16):927-36. PubMed ID: 9261580 [TBL] [Abstract][Full Text] [Related]
26. Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis. Cameron JS Pediatr Nephrol; 1995 Oct; 9(5):647-62. PubMed ID: 8580033 [TBL] [Abstract][Full Text] [Related]
27. Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD. Pannekeet MM; Zemel D; Koomen GC; Struijk DG; Krediet RT Perit Dial Int; 1995; 15(6):217-25. PubMed ID: 7578497 [TBL] [Abstract][Full Text] [Related]
28. Role of imbalance of intracavity fibrin formation and removal in the pathogenesis of peritoneal lesions in CAPD. Dobbie JW; Jasani MK Perit Dial Int; 1997; 17(2):121-4. PubMed ID: 9159830 [No Abstract] [Full Text] [Related]
29. Peritoneal functional parameters after five years on continuous ambulatory peritoneal dialysis (CAPD): the effect of late peritonitis. Selgas R; Muñoz J; Cigarran S; Ramos P; L-Revuelta K; Escuin F; Miguel JL Perit Dial Int; 1989; 9(4):329-32. PubMed ID: 2577360 [TBL] [Abstract][Full Text] [Related]
30. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship. Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642 [TBL] [Abstract][Full Text] [Related]
31. The impact of peritonitis on peritoneal and systemic acid-base status of patients on continuous ambulatory peritoneal dialysis. Sennesael JJ; De Smedt GC; Van der Niepen P; Verbeelen DL Perit Dial Int; 1994; 14(1):61-5. PubMed ID: 8312417 [TBL] [Abstract][Full Text] [Related]
32. Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPD. Zemel D; Betjes MG; Dinkla C; Struijk DG; Krediet RT Perit Dial Int; 1995; 15(2):134-41. PubMed ID: 7612733 [TBL] [Abstract][Full Text] [Related]
33. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis. Izumotani T; Ishimura E; Yamamoto T; Otoshi T; Okuno S; Inaba M; Kim M; Nishizawa Y Nephron; 2001 Sep; 89(1):43-9. PubMed ID: 11528231 [TBL] [Abstract][Full Text] [Related]
34. Gene expression and release of interleukin-8 by peritoneal macrophages and polymorphonuclear leukocytes during peritonitis in uremic patients on continuous ambulatory peritoneal dialysis. Lin CY; Huang TP Nephron; 1994; 68(4):437-41. PubMed ID: 7870228 [TBL] [Abstract][Full Text] [Related]
35. Changes in the expression of adhesion molecules as peripheral blood monocytes differentiate into peritoneal macrophages. Faull RJ; Wang J; Stavros W Nephrol Dial Transplant; 1996 Oct; 11(10):2037-44. PubMed ID: 8918719 [TBL] [Abstract][Full Text] [Related]
36. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688 [TBL] [Abstract][Full Text] [Related]
38. An autopsy study of the peritoneal cavity from patients on continuous ambulatory peritoneal dialysis. Rubin J; Herrera GA; Collins D Am J Kidney Dis; 1991 Jul; 18(1):97-102. PubMed ID: 2063862 [TBL] [Abstract][Full Text] [Related]
39. Risks of peritoneal membrane failure in children undergoing long-term peritoneal dialysis. Andreoli SP; Langefeld CD; Stadler S; Smith P; Sears A; West K Pediatr Nephrol; 1993 Oct; 7(5):543-7. PubMed ID: 8251318 [TBL] [Abstract][Full Text] [Related]
40. Long-term effects of peritoneal dialysis on peritoneal morphology. Dobbie JW; Anderson JD; Hind C Perit Dial Int; 1994; 14 Suppl 3():S16-20. PubMed ID: 7948267 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]